Cargando…
Small molecule-based treatment approaches for intervertebral disc degeneration: Current options and future directions
Low back pain (LBP) is a major reason for disability, and symptomatic intervertebral disc (IVD) degeneration (IDD) contributes to roughly 40% of all LBP cases. Current treatment modalities for IDD include conservative and surgical strategies. Unfortunately, there is a significant number of patients...
Autores principales: | Kamali, Amir, Ziadlou, Reihane, Lang, Gernot, Pfannkuche, Judith, Cui, Shangbin, Li, Zhen, Richards, R. Geoff, Alini, Mauro, Grad, Sibylle |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
Ivyspring International Publisher
2021
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7681102/ https://www.ncbi.nlm.nih.gov/pubmed/33391459 http://dx.doi.org/10.7150/thno.48987 |
Ejemplares similares
-
Transcriptional profiling of intervertebral disc in a post‐traumatic early degeneration organ culture model
por: Cui, Shangbin, et al.
Publicado: (2021) -
Neoepitope fragments as biomarkers for different phenotypes of intervertebral disc degeneration
por: Cui, Shangbin, et al.
Publicado: (2022) -
Proinflammatory intervertebral disc cell and organ culture models induced by tumor necrosis factor alpha
por: Du, Jie, et al.
Publicado: (2020) -
Small molecules of herbal origin for osteoarthritis treatment: in vitro and in vivo evidence
por: Zhang, Penghui, et al.
Publicado: (2022) -
Preclinical ex-vivo Testing of Anti-inflammatory Drugs in a Bovine Intervertebral Degenerative Disc Model
por: Li, Zhen, et al.
Publicado: (2020)